Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

IRINOTECAN EPSL irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial (439203)

ARTG ID

439203

ARTG Name

IRINOTECAN EPSL irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial

Sponsor

Eugia Pharma (Australia) Pty Ltd

ARTG Date

March 17, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Eugia Pharma (Australia) Pty Ltd

Sponsor Item Name

EUGIA PHARMA (AUSTRALIA) PTY LTD

Active Ingredients

Ingredient Name

irinotecan hydrochloride trihydrate

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy